|
Market Closed -
Hong Kong S.E.
09:08:07 02/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.4450 HKD | 0.00% |
|
+3.49% | -11.00% |
| 08-28 | Mabpharm Limited Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 06-24 | Mabpharm Limited Receives Approval for New Drug Application of CMAB807X (Denosumab Injection) | CI |
Chart: Technical Analysis
Stock exchange
Hong Kong S.E.
2181 0.4450 $
0.00%
24.92K
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Hong Kong S.E.
| 2181 | 0.4450HKD | 0.00% | 24.92K $ |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bearish | Bearish |
| Resistance | 0.445 | 0.51 | 0.51 |
| Spread/Res. | +0.00% | -12.75% | -12.75% |
| Spread/Supp. | +5.95% | +20.27% | +17.11% |
| Support | 0.42 | 0.37 | 0.38 |
- Stock Market
- Stocks
- 2181 Stock
- Charts Mabpharm Limited
Select your edition
All financial news and data tailored to specific country editions
